This product is supplied exclusively for in-vitro laboratory research use. It is not intended for human or animal use, including diagnosis, treatment, mitigation, or prevention of disease.
Tirzepatide 10mg
$85Purity: 99.749%
Independently Tested
Freedom Diagnostics — USA Lab
Product ID
TIRZEPATIDE
Purity
99.749%
Dosage
10mg
Category
Weight Loss
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | 4,813 Da |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser |
| CAS Number | 2023788-19-2 ↗ |
| Purity | 99.749% HPLC |
| Form | Lyophilized Powder |
| Storage | -20°C / -4°F |
Tested by Freedom Diagnostics
HPLC + Mass Spectrometry · USA Lab
About Tirzepatide
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist — often called a "twincretin" — representing a fundamentally new approach to metabolic research. This 39-amino acid synthetic peptide is based on the native GIP sequence with strategic modifications including Aib substitutions at positions 2 and 13, and a C20 fatty diacid chain attached at Lys20 via a linker, conferring a ~5-day half-life through albumin binding.
Research-grade Tirzepatide at 10mg/vial enables investigation of synergistic incretin signaling pathways that cannot be studied with single-agonist compounds. The dual receptor activation produces distinct downstream effects compared to GLP-1 agonism alone, making Tirzepatide essential for researchers studying the relative contributions of GIP vs. GLP-1 pathways to metabolic homeostasis.
Pure Pharm Peptides' Tirzepatide is verified at 99.749% purity by independent HPLC analysis, ensuring research-grade quality for reliable experimental outcomes.
Research Applications:
- Comparative GIP vs. GLP-1 receptor signaling studies
- Dual incretin pathway synergy investigations
- Adipose tissue metabolism and lipolysis research
- Pancreatic beta-cell function under dual incretin stimulation
- Metabolic syndrome, obesity, and type 2 diabetes model studies
- Cardiovascular and hepatic lipid metabolism research
Key Specifications:
- Purity: 99.749% verified by Freedom Diagnostics testing
- Dosage: 10mg per vial
- Category: Weight Loss
- Storage: -20°C or colder (lyophilized)
- Stability: Up to 2 years when stored properly
Research Highlights:
- 99.749% purity — highest in our metabolic research peptide lineup
- First dual GIP/GLP-1 receptor agonist ('twincretin') available for research
- ~5-day half-life enables less frequent dosing in chronic study protocols
- 10mg/vial — larger quantity for extended research programs
- Molecular weight: 4,813 Da | CAS: 2023788-19-2 | PubChem CID: 156588324
Tirzepatide 10mg
Tirzepatide is a next-generation peptide for weight loss research, often called a 'twincretin' because it targets two different pathways for appetite control. This dual-action approach has shown even more impressive results in studies, making it a top choice for researchers looking for significant and sustained weight reduction.
Frequently Asked Questions — Tirzepatide
Customer Reviews
No reviews yet
Share & Earn Rewards
Earn $10 when someone buys through your link!
We Accept
Zelle
CryptoMore Options via EmailPayPal, Cash App & more available — select "More Payment Options" at checkout.
Share:
Frequently Researched Together
Stay Updated on Research Peptides
Get exclusive updates on new products, COA releases, and research insights delivered to your inbox.
The verified choice for researchers who demand proof, not just claims. Tested by Freedom Diagnostics.
For research purposes only.
Company
Contact
Freedom Diagnostics
Accredited USA Laboratory
WE ACCEPT
© 2026 Pure Pharm Peptides. All rights reserved.
Tirzepatide
$85